Neuro-psych Drugs Flashcards
Role of tertiary amines in TCAs
Have two methyl groups in side chain with dominant effect on serotonin reuptake
Role of secondary amines in TCAs
Single methyl group with dominant effect on norepinephrine reuptake
TCA pharmacokinetics
Good GI absorption but high first pass (50%)
Large Vd
Liver metabolism
Long half-life >24hrs
Adverse effects of TCAs
Dry mouth (xerostomia)
Urinary hesitancy
Decreased gastric motility
Blurred vision
Orthostatic hypotension
Cardiac effects of TCAs
Increased Arrhythmogenicity
-tachycardia/palpitations
-Prolonged QTc
-narrow therapeutic index should be considered in patients with suicidal ideation
Anesthesia Implications: TCAs
Exaggerated response to indirect Sympathomimetics- ephedrine
Prolonged use- adrenergic desensitization and catecholamine depletion=vasoplegia
Pro-arrhythmic effect with volatiles
SSRI mechanism
5-HTT inhibition and modulation of post synaptic 5-HT receptors
Also production of neuroprotective proteins along with anti-inflammatory effects
SSRI pharmacokinetics
Hepatic metabolism
Most have inactive metabolites
Half-life about a day- can take weeks for adverse reactions to resolve completely
SSRI adverse effects
Mostly well tolerated
Sexual dysfunction, weight changes, dizziness, sleep disturbances
Serotonin syndrome- agitation-increased sympathetic outflow, can mimic malignant hyperthermia, -usually occurs in combination with other drugs modulating serotonin activity
SSRI anesthetic considerations
Prolonged QTC
Inhibit platelet aggregation
Serotonin syndrome
MAOI mechanism
Irreversibly binds MAO, inhibits enzyme for up to two weeks
MAO-A
Metabolizes via deamination: serotonin, epinephrine, norepinephrine, melatonin, dopamine, tryptamine
MAO-B
Metabolizes via deamination: phenylethylamine, tyramine, dopamine, tryptamine,
Adverse effects of MAOIs
Avoid foods containing large amounts of tyramine
Orthostatic hypotension
MAOI drug interactions
Indirect acting Sympathomimetics may case hypertensive crisis
AVOID ephedrine
AVOID phenylpiperidine opioids, especially meperidine=life threatening hypertensive crisis
Morphine is opioid of choice
First generation antipsychotics
Blockade of D2 dopamine receptors
Compazine
Phenergan
Haldol
Reglan
Not commonly given due to high incidence of adverse effects
Extrapyramidal symptoms
Involuntary movement disorders
Dystonia-acute spasm/muscle contraction-give anti cholinergic to reverse- can occur after one dose
Akathesia- restlessness-same treatment
Pseudoparkinsonism- generally reversible- typically don’t give dopamine antagonists with Parkinson’s since it exacerbates symptoms
Tardive dyskinesia
Choreoathetoid movements (wormlike)
From Chronic therapy
Anticholinergic agents may worsen TD
Administration of D2 antagonist will exacerbate TD